BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9022727)

  • 1. AutoPap system performance in screening for low prevalence and small cell abnormalities.
    Lee JS; Wilhelm P; Kuan L; Ellison DG; Lei X; Oh S; Patten SF
    Acta Cytol; 1997; 41(1):56-64. PubMed ID: 9022727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A feasibility study of the AutoPap system location-guided screening.
    Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
    Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
    Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
    Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: II. Prospective and archival sensitivity studies.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):343-7. PubMed ID: 9438459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AutoPap 300 QC system scoring of cervical smears without "epithelial cell abnormalities".
    Colgan TJ; Bon N; Lee JS; Patten SF
    Acta Cytol; 1997; 41(1):45-9. PubMed ID: 9022725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity studies of AutoPap System Location-Guided Screening of cervical-vaginal cytologic smears.
    Huang TW; Lin TS; Lee JS
    Acta Cytol; 1999; 43(3):363-8. PubMed ID: 10349363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does use of the AutoPap assisted primary screener improve cytologic diagnosis?
    Bibbo M; Hawthorne C; Zimmerman B
    Acta Cytol; 1999; 43(1):23-6. PubMed ID: 9987445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of high grade squamous intraepithelial lesions and tumors using the AutoPap System: results of a primary screening clinical trial.
    Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ; Dax Taylor D
    Cancer; 1999 Dec; 87(6):354-8. PubMed ID: 10603189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAPNET testing for HSILs. The few cell/small cell challenge.
    Solomon HM; Frist S
    Acta Cytol; 1998; 42(1):253-9. PubMed ID: 9479348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The primary screening clinical trials of the TriPath AutoPap System.
    Wilbur DC; Norton MK
    Epidemiology; 2002 May; 13 Suppl 3():S30-3. PubMed ID: 12071481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ThinPrep Pap test. A review of clinical studies.
    Linder J; Zahniser D
    Acta Cytol; 1997; 41(1):30-8. PubMed ID: 9022723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears. Including initial biopsy results.
    Bishop JW; Bigner SH; Colgan TJ; Husain M; Howell LP; McIntosh KM; Taylor DA; Sadeghi MH
    Acta Cytol; 1998; 42(1):189-97. PubMed ID: 9479339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of AutoPap primary screening system sensitivity and high-risk performance.
    Tench WD
    Acta Cytol; 2002; 46(2):296-302. PubMed ID: 11917576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative cervical smears before CIN 3/carcinoma. Reevaluation with the PAPNET Testing System.
    Doornewaard H; van de Seijp H; Woudt JM; van der Graaf Y; van den Tweel JG
    Acta Cytol; 1997; 41(1):74-8. PubMed ID: 9022729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased detection of epithelial cell abnormalities by liquid-based gynecologic cytology preparations. A review of accumulated data.
    Austin RM; Ramzy I
    Acta Cytol; 1998; 42(1):178-84. PubMed ID: 9479337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing the performance of the AutoPap 300 QC system with optimal staining and presentation of cervical smears.
    Colgan TJ; Smith J; Patten SF; Lee JS
    Acta Cytol; 1997; 41(1):50-5. PubMed ID: 9022726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the AutoPap Primary Screening System in the detection of high-risk cases in cervicovaginal smears.
    Alasio LM; Alphandery C; Grassi P; Ruggeri M; De Palo G; Pilotti S
    Acta Cytol; 2001; 45(5):704-8. PubMed ID: 11575647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AutoCyte SCREEN interactive automated primary cytology screening system. A preliminary evaluation.
    Takahashi M; Kimura M; Akagi A; Naitoh M
    Acta Cytol; 1998; 42(1):185-8. PubMed ID: 9479338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.